Mangoceuticals (MGRX) EBITDA (2023 - 2026)
Mangoceuticals (MGRX) reported EBITDA of -$3.1 million for Q1 2026, up 31.69% on a YoY basis from -$2.4 million in Q1 2025, and down 750.15% sequentially from -$367739.0 in Q4 2025.
Mangoceuticals (MGRX) EBITDA (2023 - 2026) Analysis & Trends
Mangoceuticals (MGRX) has 4 years of EBITDA data on file, last reported at -$3.1 million in Q1 2026.
- For the quarter ending Q1 2026, EBITDA rose 31.69% year-over-year to -$3.1 million; the trailing twelve-month figure through Mar 2026 stood at -$16.3 million (down 60.16% YoY), and the FY2025 full-year result was -$18.0 million, down 126.2% from the prior year.
- EBITDA fell to -$3.1 million in Q1 2026, from -$367739.0 in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$367739.0 in Q4 2025 to a low of -$7.5 million in Q3 2025.
- A 4-year average of -$2.9 million and a median of -$2.4 million in 2024 frame the typical range for EBITDA.
- Peak annual rise in EBITDA reached 78.08% in 2025, while the deepest fall reached 329.04% in 2025.
- Tracing MGRX's EBITDA over 4 years: stood at -$2.6 million in 2023, then jumped by 34.67% to -$1.7 million in 2024, then jumped by 78.08% to -$367739.0 in 2025, then sank by 750.15% to -$3.1 million in 2026.
- Business Quant data shows MGRX's EBITDA at -$3.1 million in Q1 2026, -$367739.0 in Q4 2025, and -$7.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 32.25 Bn | 24.94 Bn | 662.02 Mn | 273.11 Mn |
| 2 | BrightSpring Health Services | 14.59 Bn | 13.69 Bn | 482.22 Mn | 121.45 Mn |
| 3 | Healthequity | 8.33 Bn | 8.07 Bn | 256.31 Mn | 102.95 Mn |
| 4 | Hinge Health | 5.98 Bn | 5.67 Bn | 154.23 Mn | 32.07 Mn |
| 5 | 10x Genomics | 5.88 Bn | 5.34 Bn | 106.18 Mn | -17.05 Mn |
| 6 | MiniMed | 4.49 Bn | 4.20 Bn | 480.00 Mn | -93.00 Mn |
| 7 | Waystar Holding | 4.48 Bn | 4.41 Bn | 216.84 Mn | 80.47 Mn |
| 8 | Doximity | 3.97 Bn | 3.22 Bn | 125.97 Mn | 24.83 Mn |
| 9 | Privia Health | 3.13 Bn | 2.71 Bn | - | 7.42 Mn |
| 10 | Mangoceuticals | 9.14 Mn | 8.95 Mn | 29,001.00 | -3.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.13 Mn |
| Dec 31, 2025 | -367,739.00 |
| Sep 30, 2025 | -7.54 Mn |
| Jun 30, 2025 | -5.27 Mn |
| Mar 31, 2025 | -4.58 Mn |
| Dec 31, 2024 | -1.68 Mn |
| Sep 30, 2024 | -1.76 Mn |
| Jun 30, 2024 | -2.17 Mn |
| Mar 31, 2024 | -2.37 Mn |
| Dec 31, 2023 | -2.57 Mn |
| Sep 30, 2023 | -1.80 Mn |
| Jun 30, 2023 | -2.29 Mn |
| Mar 31, 2023 | -2.56 Mn |